Product Images Nuedexta

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Nuedexta NDC 59148-053 by Otsuka America Pharmaceutical, Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

The structural formula for Dextromethorphan hydrobromide is the pharmacologically active ingredient of NUEDEXTA that acts on the central nervous system (CNS). The chemical name is dextromethorphan hydrobromide: morphinan, 3-methoxy-17-methyl-, (9α, 13α, 14α), hydrobromide monohydrate. Dextromethorphan hydrobromide has the empirical formula C18H25NO•HBr•H2O with a molecular weight of 370.33. - nuedexta 01

The structural formula for Dextromethorphan hydrobromide is the pharmacologically active ingredient of NUEDEXTA that acts on the central nervous system (CNS). The chemical name is dextromethorphan hydrobromide: morphinan, 3-methoxy-17-methyl-, (9α, 13α, 14α), hydrobromide monohydrate. Dextromethorphan hydrobromide has the empirical formula C18H25NO•HBr•H2O with a molecular weight of 370.33. - nuedexta 01

The structural formula for Quinidine sulfate is a specific inhibitor of CYP2D6-dependent oxidative metabolism used in NUEDEXTA to increase the systemic bioavailability of dextromethorphan. The chemical name is quinidine sulfate: cinchonan-9-o1, 6’-methoxy-, (9S) sulfate (2:1), (salt), dihydrate. Quinidine sulfate dihydrate has the empirical formula of (C20H24N2O2)2•H2SO4•2H2O with a molecular weight of 782.96. - nuedexta 02

The structural formula for Quinidine sulfate is a specific inhibitor of CYP2D6-dependent oxidative metabolism used in NUEDEXTA to increase the systemic bioavailability of dextromethorphan. The chemical name is quinidine sulfate: cinchonan-9-o1, 6’-methoxy-, (9S) sulfate (2:1), (salt), dihydrate. Quinidine sulfate dihydrate has the empirical formula of (C20H24N2O2)2•H2SO4•2H2O with a molecular weight of 782.96. - nuedexta 02

Figure 1: Mean PBA Episode Rates by Visit - nuedexta 03

Figure 1: Mean PBA Episode Rates by Visit - nuedexta 03

Figure 2: Least Square Mean CNS-LS Scores by Visit - nuedexta 04

Figure 2: Least Square Mean CNS-LS Scores by Visit - nuedexta 04

This appears to be a table or chart displaying information about a statistical analysis of "Least Square Mean Change from Baseline CNS-LS Score" for a medication called "NUEDEXTA" over several days of visits. There are symbols and letters that cannot be interpreted, but there are statistically significant results indicated at a certain level of significance. Without further context, it is unclear what this information may mean or how it should be interpreted.*

PRINCIPAL DISPLAY PANEL - 60 Capsule Bottle Label - nuedexta 05

PRINCIPAL DISPLAY PANEL - 60 Capsule Bottle Label - nuedexta 05

NUEDEXTA is a prescription medication that contains 20 mg of dextromethorphan hydrobromide and 10 mg of quinidine sulfate per capsule. It is used as directed by a healthcare provider, and dosage instructions can be found in the package insert. It should be stored at 77°F (26°C), with excursions between 59°F-86°F (15°C-30°C) permitted as long as it is protected from light and moisture. NUEDEXTA is distributed by Otsuka America Pharmaceutical, Inc. The product has a GTIN of 0035148000000, an SN of 100000000001, an expiration date of MMAYYYY, and a unique lot number XXXXXXXX.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.